Cell cycle stage-specific phosphorylation of the Epstein-Barr virus immortalization protein EBNA-LP

Journal of Virology

Volumn 70, Issue 11, 1996, Pages 7885-7893

  Kitay, Mary Kate ^a   Rowe, David T ^a  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APHIDICOLIN; CASEIN KINASE II; CYCLIN DEPENDENT KINASE; HYDROXYUREA; NOCODAZOLE; NUCLEAR PROTEIN; PHOSPHATASE; PHOSPHOAMINO ACID; PROTEIN KINASE; SERINE; VIRUS PROTEIN;

ARTICLE; B LYMPHOCYTE; CELL CYCLE PHASE; CELL IMMORTALIZATION; CONTROLLED STUDY; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; LYMPHOBLASTOID CELL LINE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; UMBILICAL CORD BLOOD;

EID: 0029798375     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.11.7885-7893.1996     Document Type: Article

References (50)

1. Allan, G. J., G. J. Inman, B. D. Parker, D. T. Rowe, and P. J. Farrell. 1992. Cell growth effects of Epstein-Barr virus leader protein. J. Gen. Virol. 73: 1547-1551.
2. Allday, M. J., A. Sinclair, G. Parker, D. H. Crawford, and P. J. Farrell. 1995. Epstein-Barr virus efficiently immortalizes human B cells without neutralizing the function of p53. EMBO J. 14:1382-1391.
3. Barbosa, M. S., C. Edmonds, C. Fisher, J. T. Schiller, D. R. Lowy, and K. H. Vousden. 1990. The region of the HPV E7 oncoprotein homologous to adenovirus E1a and Sv40 large T antigen contains separate domains for Rb binding and casen kinase II phosphorylation. EMBO J. 9:153-160.
4. Bischoff, J. R., P. N. Friedman, D. R. Marshak, C. Prives, and D. Beach. 1990. Human p53 is phosphorylated by p60-cdc2 and cyclin B-cdc2. Proc. Natl. Acad. Sci. USA 87:4766-4770.
5. Boussel, K., M. H. Oelgeschlager, M. Henriksson, S. Schreek, H. Burkhardt, D. W. Litchfield, J. M. Luscher-Firzlaff, and B. Luscher. 1994. Regulation of transcription factors c-Myc, Max, and c-Myb by casen kinase II. Cell. Mol. Biol. Res. 40:501-511.
6. Carroll, D., N. Santoro, and D. R. Marshak. 1988. Regulating cell growth: casein-kinase-II-dependent phosphorylation of nuclear oncoproteins. Cold Spring Harbor Symp. Quant. Biol. 53:91-95.
7. Cisek, L. J., and J. L. Corden. 1989. Phosphorylation of RNA polymerase by the murine homologue of the cell-cycle control protein cdc2. Nature (London) 339:679-684.
8. Cordier-Busset, M., M. Billand, A. Calender, and G. M. Lenoir. 1993. Epstein-Barr virus (EBV) nuclear antigen 2 induced upregulation of CD21 and CD23 molecules is dependent on a permissive cellular context. Int. J. Cancer 53:153-160.
9. cdc2 protein kinase. Virology 189:111-120.
10. Dillner, J., B. Kallin, and H. Alexander. 1986. An EBV determined nuclear antigen (EBNA5) partly encoded by the transformation associated Bam-WYH region of EBV-DNA: preferential expression in lymphoblastoid cell lines. Proc. Natl. Acad. Sci. USA 83:6641-6645.
11. Finke, J., M. Rowe, B. Kallin, I. Ernberg, A. Rosen, J. Dillner, and G. Klein. 1987. Monoclonal and polyclonal antibodies against Epstein-Barr virus nuclear antigen 5 (EBNA5) detect multiple protein species in Burkitt's lymphoma and lymphoblastoid cell lines. J. Virol. 61:3870-3878.
12. Firzlaff, J. M., D. A. Galloway, R. N. Eisenmann, and B. Luscher. 1989. The E7 protein of human papillomavirus type 16 is phosphorylated by casein kinase II. New Biol. 1:44-53.
13. Grasser, F. A., P. Hais, S. Gottel, and N. Mueller-Lantzsch. 1991. Biochemical characteristics of Epstein-Barr virus nuclear antigen 2A. J. Virol. 65: 3779-3788.
14. Grossman, S. R., E. Johannsen, X. Tong, R. Yalamanchili, and E. Kieff. 1994. The Epstein-Barr virus nuclear antigen 2 recombination signal binding protein. Proc. Natl. Acad. Sci. USA 91:7568-7572.
15. Hammerschmidt, W., and B. Sugden. 1989. Genetic analysis of immortalizing functions of Epstein-Barr virus in human B lymphocytes. Nature (London) 340:393-397.
16. K. Science 265:92-95.
17. Inman, G. J., and P. J. Farrell. 1995. Epstein-Barr virus EBNA-LP and transcription regulation properties of pRb, p107 and p53 in transfection assays. J. Gen. Virol. 76:2141-2149.
18. Jiang, W.-Q., L. Szekely, V. Wendel-Hansen, N. Ringertz, G. Klein, and A. Rosen. 1991. Co-localization of the retinoblastoma protein and the Epstexin-Barr virus-encloded nuclear antigen EBNA5. Exp. Cell Res. 197:314-318.
19. Kaelin, W. G., D. C. Pallas, J. A. DeCaprio, F. J. Kaye, and D. M. Livingston. 1991. Identification of cellular proteins that can interact with the T/E1a-binding region of the retinoblastoma gene product. Cells 64:521-532.
20. Kempkes, B., D. Pich, R. Zeidler, B. Sugden, and W. Hannerschmidt. 1995. Immortalization of human B lymphocytes by a plasmid containing 71 kbp of Epstein-Barr virus DNA. J. Virol. 69:231-238.
21. Kieff, E. 1996. Epstein-Barr virus and its replication, p. 2343-2396. In B. N. Fields, D. M. Knife, et al. (ed.), Fields virology. Raven Press, New York.
22. Kipreos, E. T., and J. Y. Wang. 1990. Differential phosphorylation of c-Ab1 in cell cycle determined by cdc2 kinase and phosphatase activity. Science 248:217-220.
23. Kitay, M. K., and D. T. Rowe. 1996. Protein-protein interactions between Epstein-Barr virus nuclear antigen-LP and cellular gene products: binding of 70Kd heat shock proteins. Virology 220:91-99.
24. Kolman, J. L., N. Taylor, D. R. Marshak, and G. Miller. 1993. Serine-173 of the Epstein-Barr virus ZEBRA protein is required for DNA binding and is a target for casein kinase II phosphorylation. Proc. Natl. Acad. Sci. USA 90:10115-10119.
25. Lees, J. A., K. J. Buchkovich, D. R. Marshak, C. W. Anderson, and E. Harlow. 1991. The retinoblastoma protein is phosphorylated on multiple sites by human cdc2. EMBO J. 10:4279-4290.
26. Leibowitz, D., and E. Kieff. 1990. Epstein-Barr virus and its replication, p. 1889-1920. In B. N. Fields, D. M. Knipe, et al. (ed.), Fields virology. Raven Press, New York.
27. Lenoir, G. M., M. Vuillaume, and C. Bonnardel. 1985. Use of lymphomatous and lymphoblastoid cell lines in the study of Burkitt's lymphoma, p. 309-318. In G. M. Lenoir, G. O'Connor, and C. L. M. Olweny (ed.), Burkitt's lymphoma: a human cancer model. Scientific publication no. 60. International Agency for Research on Cancer, Lyon, France.
28. Lin, B. T.-Y., S. Gruenwald, A. O. Morta, W. H. Lee, and J. Y. J. Wang. 1991. Retinoblastoma cancer-suppressor gene product is a substrate of the cell cycle regulator cdc2 kinase. EMBO J. 10:857-864.
29. Ling, P. D., D. R. Rawlins, and S. D. Hayward. 1993. The Epstein-Barr virus immortalizing protein EBNA-2 is targeted to DNA by a cellular enhancer-binding protein. Proc. Natl. Acad. Sci. USA 90:9237-9241.
30. Litchfield, D. W., B. Luscher, F. J. Lozeman, R. N. Eisenman, and E. G. Krebs. 1992. Phosphorylation of casein kinase II by p34-cdc2 in vitro and at mitosis. J. Biol. Chem. 267:13943-13951.
31. Luscher, B., and R. N. Eisenman. 1992. Mitosis-specific phosphorylation of the nuclear oncoproteins Myc and Myb. J. Cell Biol. 118:775-784.
32. Mannick, J. B., J. I. Cohen, M. Birkenbach, A. Marchini, and E. Kieff. 1991. The Epstein-Barr virus nuclear protein encoded by the leader of the EBNA RNAs is important in B-lymphocyte transformation. J. Virol. 65:6826-6837.
33. Mannick, J. B., X. Tung, A. Hennes, and E. Kieff. 1995. The Epstein-Barr virus nuclear antigen leader protein association with hsp72/hsc73. J. Virol. 69:8169-8172.
34. Marshall, D., and C. Sample. 1995. Epstein-Barr virus nuclear antigen 3C is a transcriptional regulator. J. Virol. 69:3624-3630.
35. Matsunami, N., Y. Hamaguchi, Y. Yamamoto, K. Kuze, K. Kangawa, H. Matsuo, M. Kawaichi, and T. Honjo. 1989. A protein binding to the J kappa recombination sequence of immunoglobulin genes contains a sequence related to the integrase motif. Nature (London) 342:934-937.
36. Meek, D. W., S. Simon, D. Kikkawa, and W. Eckhart. 1990. The p53 tumor suppressor protein is phosphorylated at serine 389 by casein kinase II. EMBO J. 9:3253-3260.
37. Mosialos. R., M. Birkenbach, R. Yalamanchili, T. Van Arsdale, C. Ware, and E. Kieff. 1995. The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family. Cell 80:389-400.
38. Petti, L., C. Sample, and E. Kieff. 1990. Subnuclear localization and phosphorylation of Epstein-Barr virus latent infection nuclear protein. Virology 176:563-574.
39. Rawlins, D. R., G. Milman, S. D. Hayward, and G. S. Hayward. 1985. Sequence specific DNA binding of the Epstein-Barr virus nuclear antigen (EBNA-1) to clustered sites in the plasmid maintenance region. Cell 42:859-688.
40. Sauter, M., H. Boos, F. Hirsch, and N. Muller-Lantzsch. 1988. Characterization of a latent protein encoded by the large internal repeats and the BamHI Y fragment of the Epstein-Barr virus (EBV) genome. Virology 165:586-590.
41. Schneider, H. R., and O. G. Issinger. 1988. Nucleolin (CD23), a physiological substrate for casein kinase II. Biochem. Biophys. Res. Commun. 156: 1390-1397.
42. 1 transition during immortalization of resting human B lymphocytes by Epstein-Barr virus. EMBO J. 13:3321-3328.
43. Smith, D. B., and K. S. Johnson. 1988. Single-step purification of polypeptides expressed in E. coli as fusions with glutathione S-transferase. Gene 67:31-40.
44. Szekely, L., W. Jiang, K. Pokrovshaja, K. Wiman, G. Klein, and N. Rigerty. 1995. Reversible nucleolar translocation of Epstein-Barr virus-encoded EBNA5 and hsp70 proteins after exposure to heal shock or cell density congestion. J. Gen. Virol. 76:2423-2432.
45. Szekely, L., G. Selivanova, K. P. Magnusson, G. Klein, and K. G. Wiman. 1993. EBNA-5. an Epstein-Barr virus-encoded nuclear antigen, binds to the retinoblasloma and p53 proteins. Proc. Natl. Acad. Sci. USA 90:5455-5459.
46. Tsui, S., and W. H. Schubach. 1994. Epstein-Barr virus nuclear protein 2A forms oligomers in vitro and in vivo through a region required for B-cell transformation. J. Virol. 68:4287-4294.
47. Waltzer, L., F. Logeat, C. Broil, A. Israel, A. Sergeant, and E. Manet. 1994. The human J kappa recombination signal sequence binding protein (RBP-J kappa) targets the Epstein-Barr virus EBNA2 protein to its DNA responsive elements. EMBO J. 13:5633-5638.
48. Wilson, G., and G. Miller. 1979. Recovery of Epstein-Barr virus from nonproducer neonatal human lymphoid cell transformants. Virology 95:351-358.
49. Zimber-Strobl, U., E. Kremmer, F. Grasser, G. Marschall, G. Laux, and G. W. Bornkamm. 1993. The Epstein-Barr virus nuclear antigen 2 interacts with an EBNA2 responsive cis-element of the terminal protein 1 gene promoter. EMBO J. 12:167-175.
50. Zimber-Strobl, U., L. J. Strobl, C. Meitinger, R. Hinrichs, T. Sakai, T. Furukawa, T. Honjo, and G. W. Bornkamm. 1994. The Epstein-Barr virus nuclear antigen 2 exerts its function through interaction with recombination signal binding protein RBP-J kappa, the homologue of Drosophila suppressor of hairless. EMBO J. 13:4973-4982.